loading

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$29.99
price up icon 0.37%
$106.91
price down icon 1.35%
$95.95
price up icon 2.69%
$55.76
price up icon 2.35%
ONC ONC
$287.92
price down icon 0.92%
$157.48
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):